Literature DB >> 20031544

HapMap and mapping genes for cardiovascular disease.

Kiran Musunuru1, Sekar Kathiresan.   

Abstract

A key goal of biomedical science is to understand why individuals differ in their susceptibility to disease. Family history is among the established risk factors for most forms of cardiovascular disease, in part because inherited DNA sequence variants play a causal role in disease susceptibility. Consequently, the search for these variants has intensified over the past decade. One class of DNA sequence variants takes the form of single nucleotide changes(single nucleotide polymorphisms, or SNPs), usually with two variants or alleles for each SNP. SNPs are scattered throughout the 23 pairs of chromosomes of the human genome, and roughly 11 million common polymorphisms (ie,those > 1% frequency) are estimated to exist. A combination of SNP alleles along a chromosome is termed a haplotype. The International Haplotype Map Project was designed to create a public genome-wide database of common SNPs and, consequently, enable systematic studies of most common SNPs for their potential role in human disease. We review the following: (1) the concept of linkage disequilibrium orallelic association, (2) the HapMap project, and (3) several examples of the utility of HapMap data in genetic mapping for cardiovascular disease phenotypes.

Entities:  

Mesh:

Year:  2008        PMID: 20031544      PMCID: PMC3073405          DOI: 10.1161/CIRCGENETICS.108.813675

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  31 in total

1.  High-resolution haplotype structure in the human genome.

Authors:  M J Daly; J D Rioux; S F Schaffner; T J Hudson; E S Lander
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 5.  Genome-wide association studies: theoretical and practical concerns.

Authors:  William Y S Wang; Bryan J Barratt; David G Clayton; John A Todd
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

6.  A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.

Authors:  Dan E Arking; Arne Pfeufer; Wendy Post; W H Linda Kao; Christopher Newton-Cheh; Morna Ikeda; Kristen West; Carl Kashuk; Mahmut Akyol; Siegfried Perz; Shapour Jalilzadeh; Thomas Illig; Christian Gieger; Chao-Yu Guo; Martin G Larson; H Erich Wichmann; Eduardo Marbán; Christopher J O'Donnell; Joel N Hirschhorn; Stefan Kääb; Peter M Spooner; Thomas Meitinger; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2006-04-30       Impact factor: 38.330

7.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms.

Authors:  R Sachidanandam; D Weissman; S C Schmidt; J M Kakol; L D Stein; G Marth; S Sherry; J C Mullikin; B J Mortimore; D L Willey; S E Hunt; C G Cole; P C Coggill; C M Rice; Z Ning; J Rogers; D R Bentley; P Y Kwok; E R Mardis; R T Yeh; B Schultz; L Cook; R Davenport; M Dante; L Fulton; L Hillier; R H Waterston; J D McPherson; B Gilman; S Schaffner; W J Van Etten; D Reich; J Higgins; M J Daly; B Blumenstiel; J Baldwin; N Stange-Thomann; M C Zody; L Linton; E S Lander; D Altshuler
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

8.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

Authors:  Caroline S Fox; Helen Parise; Ralph B D'Agostino; Donald M Lloyd-Jones; Ramachandran S Vasan; Thomas J Wang; Daniel Levy; Philip A Wolf; Emelia J Benjamin
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

9.  Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.

Authors:  Donald M Lloyd-Jones; Byung-Ho Nam; Ralph B D'Agostino; Daniel Levy; Joanne M Murabito; Thomas J Wang; Peter W F Wilson; Christopher J O'Donnell
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

10.  Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.

Authors:  Marju Orho-Melander; Olle Melander; Candace Guiducci; Pablo Perez-Martinez; Dolores Corella; Charlotta Roos; Ryan Tewhey; Mark J Rieder; Jennifer Hall; Goncalo Abecasis; E Shyong Tai; Cullan Welch; Donna K Arnett; Valeriya Lyssenko; Eero Lindholm; Richa Saxena; Paul I W de Bakker; Noel Burtt; Benjamin F Voight; Joel N Hirschhorn; Katherine L Tucker; Thomas Hedner; Tiinamaija Tuomi; Bo Isomaa; Karl-Fredrik Eriksson; Marja-Riitta Taskinen; Björn Wahlstrand; Thomas E Hughes; Laurence D Parnell; Chao-Qiang Lai; Göran Berglund; Leena Peltonen; Erkki Vartiainen; Pekka Jousilahti; Aki S Havulinna; Veikko Salomaa; Peter Nilsson; Leif Groop; David Altshuler; Jose M Ordovas; Sekar Kathiresan
Journal:  Diabetes       Date:  2008-08-04       Impact factor: 9.461

View more
  8 in total

1.  Genome-wide case/control studies in hypertension: only the 'tip of the iceberg'.

Authors:  Kuixing Zhang; Alan B Weder; Eleazar Eskin; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

2.  Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions.

Authors:  Lei Cao-Lei; Salomon Carlos Leija; Robert Kumsta; Stefan Wüst; Jobst Meyer; Jonathan D Turner; Claude P Muller
Journal:  Hum Genet       Date:  2011-01-15       Impact factor: 4.132

Review 3.  Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts.

Authors:  Sanjiv J Shah
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

4.  CardioGenBase: A Literature Based Multi-Omics Database for Major Cardiovascular Diseases.

Authors:  Alexandar V; Pradeep G Nayar; R Murugesan; Beaulah Mary; Darshana P; Shiek S S J Ahmed
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

5.  Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.

Authors:  Oddgeir L Holmen; He Zhang; Yanbo Fan; Daniel H Hovelson; Ellen M Schmidt; Wei Zhou; Yanhong Guo; Ji Zhang; Arnulf Langhammer; Maja-Lisa Løchen; Santhi K Ganesh; Lars Vatten; Frank Skorpen; Håvard Dalen; Jifeng Zhang; Subramaniam Pennathur; Jin Chen; Carl Platou; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Michael Boehnke; Y Eugene Chen; Gonçalo R Abecasis; Kristian Hveem; Cristen J Willer
Journal:  Nat Genet       Date:  2014-03-16       Impact factor: 38.330

Review 6.  Genetics and heart failure: a concise guide for the clinician.

Authors:  Cecile Skrzynia; Jonathan S Berg; Monte S Willis; Brian C Jensen
Journal:  Curr Cardiol Rev       Date:  2015

7.  The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Tsuneo Konta; Yoko Shibata; Hidenori Sato; Ryo Kawasaki; Makoto Daimon; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

8.  Common rs5918 (PlA1/A2) polymorphism in the ITGB3 gene and risk of coronary artery disease.

Authors:  Mehri Khatami; Mohammad Mehdi Heidari; Sorour Soheilyfar
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.